首页> 外文OA文献 >Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases
【2h】

Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases

机译:新辅助化疗用Capecitabine Plus Oxaliplatin治疗临床血管结肠癌侵袭尿膀胱的疗效:三种情况下的报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction. We herein present three cases of locally advanced colon cancer (LACC) invading the urinary bladder, in whom combined neoadjuvant chemotherapy with surgical intervention was effective in disease control and preserving urinary function. Case Presentation. Before neoadjuvant chemotherapy, all three cases underwent loop transverse colostomy for symptomatic colonic obstruction. Case 1: after 6 courses of capecitabine plus oxaliplatin (CAPOX), we performed sigmoid colectomy and partial resection of the bladder. The histological examination revealed pathological complete response (pCR). The final diagnosis was ypStage 0 (ypT0ypN0M0). Case 2: after 13 courses of CAPOX plus bevacizumab, we performed Hartmann’s operation with partial resection of the bladder. The histological examination revealed pCR. The final diagnosis was ypStage 0 (ypT0ypN0M0). Case 3: after 6 courses of chemotherapy with CAPOX plus bevacizumab, we performed sigmoid colectomy and partial resection of the bladder. The pathological response was grade 1a according to the Japanese Classification of Colorectal Carcinoma. The final diagnosis was ypStage IIC (ypT4bypN0M0). All three cases underwent capecitabine-based adjuvant chemotherapy after radical surgery and patients are alive without recurrence. Conclusion. Neoadjuvant chemotherapy with CAPOX with or without bevacizumab followed by radical surgery could be an effective treatment option for LACC invading the urinary bladder.
机译:介绍。我们在本文中,在侵入膀胱的局部晚期结肠癌(LACC)的三种情况下,联合新辅助化疗与手术干预组合的患者在疾病控制和保护尿液功能中有效。案例演示。在Neoadjuvant化疗之前,所有三种病例都接受了横向骨囊术对症状结肠梗阻。案例1:在Capecitabine Plus oxaliplatin(Capox)的6个课程后,我们进行了乙状结肠切除术和部分切除膀胱。组织学检查显示出病理完全反应(PCR)。最终诊断为Ypstage 0(YPT0YPN0M0)。案例2:在Capox Plus Bevacizumab的13个课程后,我们通过部分切除膀胱进行Hartmann的操作。组织学检查显示PCR。最终诊断为Ypstage 0(YPT0YPN0M0)。案例3:用Capox Plus Bevacizumab 6种化疗后,我们进行了乙状结肠切除术和部分切除膀胱。根据日本直肠癌分类,病理反应是1A级。最终诊断为Ypstage IIC(YPT4bymn0m0)。所有三种案例都在自由基手术和患者中进行了基于卡硝齐的佐剂化疗,患者在没有复发的情况下活着。结论。与Capox的Neoadjuvant化学疗法有或没有Bevacizumab,然后是自由基手术可以是LACC入侵膀胱的有效治疗选择。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号